Q4 2024 · 13F-HR
BROADWOOD CAPITAL INCholdings as filed
Filed 2025-02-14 · accession 0000919574-25-001263
$1.28B
Reported value
7
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 61174X109 | MNST | MONSTER BEVERAGE CORP NEW | $436.0M | 34.1% | 8,295,690 | Common | SOLE |
| 05464C101 | AXON | AXON ENTERPRISE INC | $429.3M | 33.5% | 722,421 | Common | SOLE |
| 852312305 | STAA | STAAR SURGICAL CO | $263.5M | 20.6% | 10,848,631 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $114.9M | 8.98% | 519,920 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $20.9M | 1.64% | 41,666,255 | Common | SOLE |
| 68235C206 | IMDX | ONCOCYTE CORP | $14.9M | 1.16% | 6,244,405 | Common | SOLE |
| 81751A108 | SER | SERINA THERAPEUTICS INC | $426,947 | 0.03% | 85,219 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.